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Establishment, maintenance, and exit from pluripotency require precise coordination of a cell’s molecular
machinery. Substantial headway has been made in deciphering many aspects of this elaborate system,
particularly with respect to epigenetics, transcription, and noncoding RNAs. Less attention has been paid
to posttranscriptional regulatory processes such as alternative splicing, RNA processing and modification,
nuclear export, regulation of transcript stability, and translation. Here, we introduce the RNA binding proteins
that enable the posttranscriptional regulation of gene expression, summarizing current and ongoing research
on their roles at different regulatory points and discussing how they help script the fate of pluripotent stem
cells.Introduction
Embryonic stem cells (ESCs), which are derived from the inner
cell mass of the mammalian blastocyst, are remarkable because
they can propagate in vitro indefinitely while retaining both the
molecular identity and the pluripotent properties of the peri-im-
plantation epiblast. Consequently, ESCs provide a biologically
relevant and experimentally tractable model system for studying
regulators of cell fate and cell fate transitions in early devel-
opment. Understanding the molecular mechanisms of ESC
maintenance and differentiation is critically important not just
scientifically but also clinically, because an improved knowledge
of pluripotency and embryonic development will allow ESCs to
be more effectively utilized as an in vitro platform for disease
modeling, drug discovery, and tissue regeneration.
While the transcriptional, signaling, and epigenetic regulation
of these cells have been the primary focus of research efforts in
recent years (reviewed in Ng and Surani, 2011; Young, 2011;
Watanabe et al., 2013), posttranscriptional and translational
mechanisms of control remain relatively unexplored, despite
evidence that they play a dominant role in driving ESC fate de-
cisions. Indeed, posttranscriptional regulation has been re-
ported to account for nearly 75% of the changes in protein
levels after differentiation induced by knockdown of the tran-
scription factor Nanog (Lu et al., 2009), and it was recently
demonstrated that control over translational initiation by the
eIF4e binding proteins dramatically influences the efficiency of
reprogramming somatic cells to induced pluripotent stem cells
(iPSCs) (Tahmasebi et al., 2014). The cell controls protein levels
posttranscriptionally using a large collection of tools that in-
cludes noncoding RNAs and RNA binding proteins (RBPs).
Recent work elucidating the functions of microRNAs (miRNAs)
and long noncoding RNAs (lncRNAs) in ESCs has been
comprehensively reviewed elsewhere (Greve et al., 2013;
Ghosal et al., 2013; Wright and Ciosk, 2013; Flynn and Chang,
2014). Similarly, posttranslational regulation of protein levels
through the addition of covalent modifications also has been
discussed recently (Wang et al., 2014b). The purpose of this Re-
view is specifically to address the roles of RBPs in the mainte-
nance and differentiation of ESCs.RBPs are responsible for every event in the life of an RNA
molecule, including its capping, splicing, cleavage, nontem-
plated nucleotide addition, nucleotide editing, nuclear export,
cellular localization, stability, and translation (Keene, 2007).
Overall, little is known about RBPs: most are classified based
on computationally predicted similarities to proteins with known
RNA binding domains, and until recently, few of these predic-
tions have been verified in a cellular context in vivo. The recent
introduction of a technique termed ‘‘mRNA interactome cap-
ture,’’ which enables the identification of proteins bound to poly-
adenylated RNAs in vivo, has been a significant development for
the field (Baltz et al., 2012; Castello et al., 2012). Using this
method, several groups were able to create a comprehensive
catalog of RBPs in different mammalian cells, including 555
RBPs inmouse ESCs (Kwon et al., 2013). However, the functions
of these RBPs in ESCs and their changes in ESC differentiation
have yet to be addressed. Indeed, the mechanism of action of
only a small number of RBPs has been examined in any great
detail in the context of pluripotency. Here, we summarize current
knowledge of RBP contribution to posttranscriptional and trans-
lational regulation in ESCs, following the approximate order that
each regulatory event would be encountered as a transcript born
in the nucleus migrates into the cytoplasm and is translated into
a polypeptide (diagrammed in Figure 1). Throughout, we also
discuss potential directions of future inquiry that will allow us
to more fully appreciate the scope of RBP-mediated posttran-
scriptional and translational regulation in pluripotency.
Alternative Splicing
Alternative splicing of mRNA transcripts is probably the best-
studied area of RBP-driven posttranscriptional control in ESCs,
both in terms of the maintenance of the pluripotent state as
well as in the artificial induction of pluripotency in somatic cells.
A number of key pluripotency factors have been shown to exist
as multiple isoforms that vary in stability, function, and intra-
cellular localization due to differences in either coding exons or
untranslated regulatory sequences. For example, Oct4 has two
isoforms: Oct4A is the canonical pluripotency transcription fac-
tor expressed in ESCs and embryonal carcinoma cells, whileCell Stem Cell 15, September 4, 2014 ª2014 Elsevier Inc. 271
Figure 1. RBPs Involved in Pluripotency Act at Many Different Regulatory Steps
Summary of the RBPs and the events they regulate in the maintenance and exit from pluripotency as discussed in this Review. Starting in the nucleus, RBPs
regulate splicing (FOX2, SON, SFRS2, MBNL1, and MBNL2) and alternative polyadenylation (FIP1) simultaneously with transcription. RBPs then regulate export
of transcripts (THOC2 and THOC5). RBPs also can induce modifications to RNAs including nucleotide changes (ADAR, METTL3, and METTL14 in nucleus) and
nucleotidyl transfer (LIN28A in association with the TUTases ZCCHC6 and ZCCHC11 in the cytoplasm), which in turn influence mRNA stability and translation. In
the cytoplasm, the binding of RBPs to the 30UTRs of transcripts directly regulates mRNA stability and translation (TRIM71, PUM1, and BRF1). Translation is also
influenced by RBPs that bind the 50UTR of transcripts (NAT1, RBM35A, and PTBP1). Blue circles indicate RBPs. RBP genes in red are positive regulators of
pluripotency. RBP genes in green are negative regulators of pluripotency. Black circles indicate the protein products of the genes whose expression levels are
affected by RBPs.
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pressed in nonpluripotent cells (Atlasi et al., 2008). Intriguingly,
Oct4 was identified in the HeLa mRNA interactome (Castello
et al., 2012), raising the possibility that certain isoforms of Oct4
could be acting as RBPs in particular cell types. Other important
alternatively spliced genes affiliated with the ESC state include
Sall4, which has two isoforms that play collaborative roles in
maintaining pluripotency; Tcf3, whose two isoforms inhibit
Nanog and Oct4 transcription to different degrees (reviewed in
Cheong and Lufkin, 2011); Nanog, whose three isoforms main-
tain ESC pluripotency with varying efficacies (Das et al., 2011);
and DNMT3B, whose 40 isoforms are each differentially ex-
pressed in pluripotent cells and various distinct tissue types (Go-
palakrishnan et al., 2009). An especially well-developed story is
that of Foxp1, which possesses several isoforms, including
one that is uniquely expressed in ESCs. This particular transcript
contains an exon variant that encodes an altered forkhead
domain, yielding an ESC-specific Foxp1 with a DNA binding
motif different from the canonical Foxp1 consensus motif.
Demonstrating the dramatic impact of this change in sequence
specificity, only the ESC form of Foxp1 can stimulate the tran-
scription of pluripotency genes and repress ESC differentiation
genes (Gabut et al., 2011). Thus, this interesting example shows
how alternative splicing can be an integral part of the switch that
regulates the choice between self-renewal and differentiation.
Transcript splicing is mediated by a core set of proteins and
small nuclear RNAs that comprise the spliceosome, but addi-
tional RBPs are critical for dictating the spatial and temporal
specificity of splicing events needed to drive tissue-specific
expression of mRNA isoforms. Despite the obvious importance
of this posttranscriptional phenomenon, the RBPs that enable
the establishment and maintenance of the ESC splicing signa-
ture have only begun to be deciphered. Thus far, both positive272 Cell Stem Cell 15, September 4, 2014 ª2014 Elsevier Inc.(FOX2, SON, and SFRS2) and negative (MBNL1 and MBNL2)
regulators of the ESC-specific splicing signature have been iden-
tified; the list of RBPs involved is sure to increase as research in
this area expands.
In human ESCs (hESCs), FOX2 (RBM9 and FXH) promotes
exon exclusion when bound to the upstream flanking intron
and exon inclusion when bound to the downstream flanking
intron, as demonstrated by crosslinking immunoprecipitation
with high-throughput sequencing (CLIP-seq). Interestingly,
many FOX2 targets are splicing factors as well, which suggests
that FOX2 is an upstreammaster regulator of splicing regulators.
FOX2 activity is critical for pluripotency, because depletion of the
gene leads to hESC differentiation and death, thus highlighting
the functional importance of active maintenance of the ESC
splicing program (Yeo et al., 2009).
Another RBP critical for maintaining the hESC-specific com-
plement of transcript variants is the spliceosome-associated
factor SON. A genome-wide RNAi screen found that knockdown
of SON caused hESC differentiation. Sequencing of wild-type
and SON-depleted hESCs demonstrated that SON specifically
targets short introns with GC-rich weak splice sites, and in the
absence of SON, the transcripts of a number of key pluripotency
genes like OCT4 and PRDM14 have aberrant inclusion of introns,
leading to their degradation by nonsense-mediated decay (Lu
et al., 2013). Like FOX2, then, SON helps create a splicing signa-
ture important for specifying and maintaining the pluripotent
state.
A third splicing factor that positively regulates the self-renew-
ing state of hESCs was described in a recent report (Lu et al.,
2014). Sifting through transcriptome and proteome data
comparing hESCs and hiPSCs with fibroblasts, these authors
identified SFRS2 as the most enriched splicing factor in pluripo-
tent cells and MBD2 as the most differentially spliced transcript.
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(MBD2a–MBD2c), withMBD2c enriched in pluripotent stem cells
andMBD2a in fibroblasts. Stable knockdown of SFRS2 in hESCs
reduces expression of pluripotency genes and is associated with
an isoform switch fromMBD2c to MBD2a due to SFRS2 binding
upstream of an exon unique to MBD2c. While overexpression
of MBD2a promotes hESC differentiation, overexpression of
MBD2c enhanced reprogramming of fibroblasts to hiPSCs.
Interestingly, MBD2 had previously been identified as one of
the miR-302 mRNA targets partially underlying the ability of
this family of miRNAs to promote somatic cell reprogramming
(Lee et al., 2013; Subramanyam et al., 2011). Here, the authors
show that miR-302 specifically targets MBD2a, but not
MBD2c, suggesting that the effect of MBD2 on pluripotency is
isoform dependent. In sum, SFRS2 provides an exciting
example of how multiple regulatory pathways can cooperate to
promote the pluripotent state.
In contrast to the positive regulators of ESC self-renewal
described above, MBNL1 andMBNL2 repress ESC splicing pat-
terns. Knockdown of either gene causes both human andmouse
somatic cell lines to shift toward an ESC-like splicing pattern,
including the acquisition of the ESC isoform of Foxp1. Moreover,
depletion of Mbnl1 and Mbnl2 improved the efficiency of mouse
somatic cell reprogramming of MEFs. Splicing code analysis in
human and mouse ESCs suggests that the presence of Mbnl
binding sites upstreamof an exon is associatedwith its inclusion,
while downstream binding is associated with exclusion—a
pattern of binding opposite to that of FOX2 (Han et al., 2013).
Together, the examples of FOX2, SON, SFRS2, and MBNL1/2
reveal a very active role for RBPs that regulate splicing in both
self-renewal and differentiation conditions. Determining how
RBPs regulate splicing programs in cell fate choices encoun-
tered during the development of the three embryonic germ layers
as well as the germline will be an important area of future pursuit.
Alternative 30UTR Cleavage and Polyadenylation
In addition to varying the combination of coding exons that are
included in an mRNA molecule, posttranscriptional regulatory
machineries influence the processing of the 30 ends of tran-
scripts. Many mammalian genes contain more than one polya-
denylation site that can be recognized for cleavage and addition
of the poly(A) tail, and current estimates suggest that upward of
50%–70% of mammalian RNAs are subject to alternative polya-
denylation (APA), leading to transcripts with varying 30UTR
lengths (Shepard et al., 2011; Derti et al., 2012). APA appears
to be closely linked with cell state: for example, ESC differentia-
tion and embryonic development is associated with 30UTR
lengthening (Ji et al., 2009; Shepard et al., 2011), while prolifera-
tion and somatic cell reprogramming are accompanied by 30UTR
shortening (Sandberg et al., 2008; Ji and Tian, 2009). This is
thought to occur because the length of the 30UTR can affect
the availability of RBP and miRNA binding sites that are critical
for determining transcript stability, localization, and translation.
Indeed, there have been a few notable examples of how
mRNA isoforms with shorter 30UTRs can be more stable (Mayr
and Bartel, 2009, Boutet et al., 2012) and more efficiently trans-
lated (Sandberg et al., 2008) than their longer counterparts due
to differential inclusion of repressive miRNA binding sites. How-
ever, the biological roles of APA remain unclear at the globallevel, because sequencing studies, including one recently con-
ducted in NIH 3T3 fibroblasts, have shown that long and short
30UTR mRNA isoforms of the same genes have comparable sta-
bility and translation levels (Spies et al., 2013). These obser-
vations suggest, among other possibilities, that the effects of
APA on transcript stability and translation may be specific to
certain subsets of biologically important genes, while for the ma-
jority of transcripts, APA primarily serves some other regulatory
purpose, such as intracellular localization (Spies et al., 2013).
Transcript cleavage and polyadenylation occur through the
cooperation of several protein complexes: cleavage and polya-
denylation specificity factor (CPSF) recognizes the polyadenyla-
tion signal (PAS) upstream of the cleavage site, while cleavage
stimulating factor (CSTF) recognize downstream sequence ele-
ments (DSEs), and this leads to the recruitment of cleavage fac-
tor I and II, poly(A) binding proteins, and poly(A) polymerase
(reviewed in Elkon et al., 2013). Interestingly, one of the protein
subunits of CPSF, Fip1, was recently described to play a role
in creating the APA profile of ESCs (Lackford et al., 2014).
Consistent with its being important in pluripotency, Fip1 knock-
down in ESCs promoted differentiation. Deep sequencing re-
vealed that Fip1 depletion alters the APA profile of 374 genes,
with most displaying a lengthening of their 30UTR by shifting to
the more distal PAS (proximal-to-distal shift [PtoD]). The genes
showing PtoD were generally more highly expressed in self-re-
newing conditions than in differentiation conditions, and knock-
down of a representative set partially recapitulated the Fip1
knockdown phenotype. Individual nucleotide crosslinking and
immunoprecipitation followed by high-throughput sequencing
(iCLIP-seq) showed that Fip1 binds U-rich sequences upstream
of PAS sequences. Interestingly, when the PASswere located far
apart, Fip1 bound upstream of the proximal PAS and promoted
cleavage and polyadenylation at that site. However, when the
PASs were close together, Fip1 promoted usage of the distal
site. Given these data, the authors propose a model in which
Fip1 promotes cleavage and polyadenylation at all PASswith up-
stream U-rich regions. However, when Fip1 is highly expressed,
as it is in ESCs, it will bind and promote cleavage of the weaker
proximal PAS, if there is a sufficient delay in transcription be-
tween the two PAS sites. This interesting model demonstrates
how a general CPSF factor can regulate pluripotency by linking
30UTR length with production of critical self-renewal factors. It
will be important to investigate whether these results are unique
to Fip1 or whether there are additional factors in ESCs that are
critical for determining PAS usage in other sets of genes.
RNA Modification
Posttranscriptional RNA modification offers another exciting
means for improved control over transcript levels and even
increased proteomic diversity without the need tomake changes
to the genome. In regulatory regions, sequence alterations can
affect transcript stability and translation efficiency, while in tran-
script coding regions, nucleotide changes can increase protein
product diversity. RNA modifications can be separated into
two types: the nontemplated addition of nucleotides and the
chemical modification of templated bases. A well-established
example of the former is the addition of nucleotides to the 30
ends of RNAmolecules. For instance, addition of uridines (uridy-
lation) to pre-let-7 miRNA leads to its degradation in ESCs. InCell Stem Cell 15, September 4, 2014 ª2014 Elsevier Inc. 273
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Zcchc11 and Zcchc6, are directed by the RBP Lin28a to add a
string of approximately 11 uridines to the pre-miRNA (Heo
et al., 2008; Hagan et al., 2009). Oligouridylated pre-let-7 is
then recognized by the DIS3L2 exoribonuclease, which cata-
lyzes transcript degradation (Ustianenko et al., 2013). Inter-
estingly, the addition of a single uridine has the opposite effect,
promoting the processing of let-7 to its mature form (Heo et al.,
2012). The remarkable number of pathways regulating let-7 ac-
tivity befits its important role in promoting ESC differentiation
and blocking reprogramming of somatic cells to iPSCs (Melton
et al., 2010).
Although the existence of base modifications has been known
for some time, their potential regulatory roles in mammalian cell
fate decisions are just beginning to be uncovered. For example,
the RNA editing enzymeAdar (Adar1) catalyzes the conversion of
adenosine to inosine, which is subsequently read as guanosine
by the translation machinery. Adar can target both mRNAs and
dsRNA precursors of endo-siRNAs and miRNAs. In hESCs,
ADAR was shown to drive A-to-I editing across the transcrip-
tome, particularly in Alu repetitive elements. Furthermore, tran-
sient ADAR knockdown with an siRNA decreased A-to-I editing
and led to an increase in the mRNA expression of genes associ-
ated with differentiation and development, although the ADAR-
depleted ESCs did not exhibit significant morphological changes
compared to wild-type (Osenberg et al., 2010). These results
were based on the effects of a single transiently transfected
siRNA, so it will be important to further examine the role of
Adar by multiple different siRNAs, stable shRNA knockdown,
and/or genetic deletion to rule out the possibility of off-target ef-
fects and to separate the effects of acute versus chronic loss of
Adar. Moreover, the direct downstream consequences of A-to-I
editing on targeted transcripts in ESCs remain to be elucidated.
It is important to note that Adar has been found to have a number
of different roles in other cellular systems. In a complex with
Elavl1 (HuR), for example, Adar modulates mRNA stability
(Wang et al., 2013a). Adar can also affect miRNA processing
both negatively and positively, editing pri-miRNA transcripts to
prevent Microprocessor cleavage (Wu et al., 2011) or dimerizing
with Dicer in an RNA-dependent way to promote pre-miRNA
cleavage (Ota et al., 2013). But because these studies were
conducted in non-ESC cell lines, it would bemeaningful to inves-
tigate whether these other diverse functions of Adar are also rele-
vant in ESCs.
While ADAR-driven A-to-I base conversion is clearly important,
methylation of adenosine to form N6-methyladenosine (m6A) is
the most prevalent chemical modification of eukaryotic mRNA.
Enriched at stop codons and 30UTRs, the presence ofm6Amarks
appears to influence many aspects of RNA metabolism. Indeed,
recent evidence suggests that methylation at internal positions
within transcripts is associated with transcript destabilization,
while methylation at the transcriptional start site enhances trans-
lation (Schwartz et al., 2014). Biochemical studies recently re-
vealed that these m6A marks are primarily deposited by the
methyltransferases Mettl14 and Mettl3, which function together
as a heterodimer (Liu et al., 2014). In mESCs, stable shRNA
knockdown of eitherMettl3 orMettl14 greatly reducesm6A levels
and impairs ESC self-renewal (Wang et al., 2014a). Interestingly,
m6A-immunoprecipitation and sequencing (meRIP-seq) re-274 Cell Stem Cell 15, September 4, 2014 ª2014 Elsevier Inc.vealed that mRNAs of epigenetically poised developmental reg-
ulators (marked by H3K4me3 and H3K27me3 bivalent chromatin
domains) are normally highly methylated, and these genes are
upregulated inMettl3- orMettl14-depleted cells due to increased
transcript half-life. These data suggest that m6A destabilizes
transcripts. Further examining the mechanistic connection be-
tween methylation and RNA stability, the authors found that
Mettl3/Mettl14 knockdown is associated with increased binding
of the RBP HuR near m6A sites and leads to increased transcript
stability, suggesting that HuR competes with Mettl3/Mettl14 and
that their differential expression dynamically regulates RNA half-
life. While it will be important to confirm these results in a genetic
knockout systemand further investigate themechanism ofmeth-
ylated RNA destabilization, this study is intriguing for raising the
idea that, like DNA methylation and chromatin modifications,
‘‘epigenetic’’ modification of RNA can be critical for determining
cell identity.
Finally, the connections to HuR seen with both Adar- and
Mettl3/Mettl14-mediated RNA editing are tantalizing, because
HuR is also known to regulate transcript stability by either coop-
erating with or antagonizing miRNAs through a variety of
different, context-dependent mechanisms. Additionally, HuR
expression is itself modulated by miRNAs (reviewed in Simone
and Keene, 2013). Together these studies exemplify how RNA
modifications, RBPs, and miRNAs can function together to con-
trol steady-state mRNA expression levels.
Nuclear Export
In addition to directly altering the transcript sequences through
alternative splicing, alternative polyadenylation, and nucleotide
modifications, RNA fate can be influenced by the regulation of
transport between the nucleus and cytoplasm, which controls
protein levels bymodulating access to the translationmachinery.
An exciting recent study has shown that such regulation can play
a significant role in ESCs (Wang et al., 2013b). In an RNAi screen
for factors that are required for ESC self-renewal, Hu and col-
leagues identified Thoc2 and Thoc5, two members of the THO
complex, which provide an interface between nuclear transcrip-
tion and RNA export. The authors show that knockdown of
Thoc2 and Thoc5 does not alter overall transcript levels but
rather leads to a nuclear accumulation of a subset of pluripo-
tency mRNAs, including Nanog, Sox2, Klf4, and Esrrb. Immuno-
precipitation followed by deep sequencing further showed that
Thoc2 binds a subset of mRNAs in a Thoc5-dependent manner.
Interestingly, Thoc5 is believed to be an adaptor protein, and its
expression is downregulated with ESC differentiation. Overex-
pression of Thoc5 delays ESC differentiation, while knockdown
promotes ESC differentiation and blocks somatic cell reprog-
ramming. Therefore, the downregulation of Thoc5 that occurs
during normal development appears to be critical for silencing
parts of the pluripotency program and thus promoting differenti-
ation. These findings uncover a new aspect of posttranscrip-
tional control in pluripotency and may be just the first of many
more examples to come of transcript-specific nuclear export
influencing early embryonic cell fate decisions.
Regulation of mRNA Stability
Whether amolecule of RNA is stable or is quickly degraded in the
cytoplasm governs, to a large extent, its ultimate protein
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types (Neff et al., 2012), is strongly influenced by RBP and
miRNA binding, particularly at the 30UTR. Three RBPs that
have been implicated in this mode of regulation are Trim71
(mLin41), Pum1, and Brf1 (zfp36l1).
The role of Trim71 is noteworthy because it demonstrates an
interconnection among multiple protein complexes. miRNAs,
which typically regulate transcript stability and translation by
binding to 30UTRs, are critical for enabling the rapid proliferation
of ESCs by shortening theG1 phase of the cell cycle (Wang et al.,
2008, 2013c), and Gregory and colleagues found that Trim71 is
important for facilitating this activity (Chang et al., 2012). Using
immunoprecipitation followed bymass spectrometry, they found
that Trim71 binds to miRNA-containing Ago2 complexes.
Through this molecular interaction, Trim71 cooperates with
ESC-specific miR-290 and miR-302 to bind to the 30UTR of
Cdkn1a and inhibit its translation. Because Cdkn1a is a negative
regulator of the G1-S transition, the miRNA-dependent 30UTR
activity of Trim71 promotes the cell cycle structure necessary
for ESC self-renewal. Importantly, Trim71 function is tightly
incorporated into a larger intracellular network because it is a
target of the prodifferentiation miRNA let-7, whose biogenesis
is inhibited by the RBP Lin28a (see the subsection ‘‘Multifunc-
tional RBPs,’’ below). Adding to the complexity of this regulatory
circuit, another study found that Trim71 is also an E3 ubiquitin
ligase for Ago2 and showed through luciferase assays that
Trim71 cooperates with Lin28a to inhibit let-7 activity (Rybak
et al., 2009). AlthoughChang et al. (2012) did not detect a change
in Ago2 levels upon perturbation of Trim71 expression, the work
from these two groups clearly establishes Trim71 as a key player
in several dimensions of miRNA-mediated ESC regulation.
Intriguingly, more recent studies suggest that Trim71 also asso-
ciates directly with somemRNAs at their 30UTRs, independent of
miRNA involvement, and that this interaction drives transcript
degradation and inhibits translation (Loedige et al., 2013, Wor-
ringer et al., 2014). Filipowicz and colleagues used luciferase as-
says to demonstrate Trim71 binding to the 30UTRs of a subset of
prodifferentiation genes, which led to a decrease in mRNA and
protein levels in an Ago2-independent fashion (Loedige et al.,
2013). Yamanaka and colleagues showed that upregulation of
Trim71 enhanced human somatic cell reprogramming in part
by directly binding to the mRNA of the fibroblast-enriched
transcription factor EGR1 and decreasing its protein levels (Wor-
ringer et al., 2014). Using deletion mutants, both of these groups
showed that these direct effects on transcript repression do not
involve the E3 ubiquitin ligase domain of Trim71. From all of
these studies, it is clear that the story of Trim71 is highly com-
plex, and further investigations will likely expand the scope of
this RBP’s involvement in the regulation of pluripotency.
In contrast to Trim71, Pum1 appears to be a negative regu-
lator of the ESC state. Pum1 is a member of the evolutionarily
conserved PUF family of RBPs first characterized in Drosophila
and C. elegans as inhibitors of translation and mRNA stability
at the 30UTR. A transposon-mediated mutagenesis screen
in haploid ESCs found that Pum1 disruption promoted self-
renewal in an ESC-like state when the cells were cultured in
conditions permissive to differentiation (Leeb et al., 2014).
This phenotype appeared to be mediated by Pum1 binding to
its canonical eight-nucleotide motif in the 30UTRs of multiplepluripotency genes, such as Tfcp21l, Esrrb, Klf2, and Sox2,
which was associated with a decrease in their transcript levels,
presumably through increased degradation of the mRNA. In
addition to establishing a new role for Pum1 in ESCs, this study
exemplifies the importance of RBP-30UTR interactions in the
maintenance of a unique cell state. Lastly, Pum1 has a closely
related PUF family member, Pum2, which is a translational
repressor in germ cell development (Moore et al., 2003).
Because Pum2 is highly expressed in ESCs (Moore et al.,
2003), it will be important to determine how these two PUF pro-
teins genetically interact in the context of ESC self-renewal and
differentiation.
Another RBP that destabilizes pluripotency transcripts is the
AU-rich element mRNA-binding protein (AUBP) Brf1. AUBPs
are known to be developmentally important regulators of
splicing, stability, translation, and localization, and Brf1 is crit-
ical in embryogenesis: knockout mice die by E10.5 (Stumpo
et al., 2004). A recent study found that activation of the FGF-
Erk signaling pathway, which stimulates mouse ESC differenti-
ation, leads to upregulation of Brf1 (Tan and Elowitz, 2014).
Brf1 overexpression under pluripotency conditions impaired
ESC proliferation, and under differentiation conditions it pro-
moted the acquisition of mesendoderm fate. RNA immunopre-
cipitation and sequencing (RIP-seq) showed that Brf1 binds to
AU-rich elements (AREs) in a number of pluripotency mRNAs,
including Nanog, Klf2, Kdm4c, and Zfp143. Moreover, FGF
stimulation led to degradation of Nanog transcripts in an ARE-
dependent fashion, implicating Brf1 in mRNA destabilization
and ESC differentiation. Future work will likely reveal more roles
for AREs and other AUBPs in pluripotency and early embryonic
development.
With all of these RBPs involved in determining the stability of
different mRNA transcripts, it will be interesting to explore to
what extent their targets overlap and whether they cooperate
to coregulate a particular subset of transcripts. For thosemRNAs
with binding sites for several RBPs, it would furthermore be
worthwhile to examine how the relative RBP concentrations
and motif binding affinities affect transcript levels.
Regulation of Translation
RBPs can also directly modulate protein translation, often
through binding at the 50UTR of RNA transcripts. In so doing,
RBPs recruit translation initiation factors, adjust the accessibility
of the RNA to ribosomes, create ribonucleoprotein structures
conducive for cap-independent and internal ribosome entry
site (IRES)-mediated translation, and regulate the movement of
the ribosomes along the transcript. Given these many roles, it
is no surprise that RBPs involved in these 50UTR-related pro-
cesses have also been linked to the control of ESC pluripotency.
In particular, RBP-50UTR interactions involving the proteins
Nat1, Rbm35a (Esrp1), and Ptbp1 have been shown to regulate
ESC differentiation and proliferation.
Nat1 was first identified in liver carcinomas as a general
repressor of translation. In mouse ESCs, depletion of Nat1
does not affect proliferation and self-renewal in ESC growth con-
ditions, but Nat1/ ESCs exhibit a defect in retinoic acid (RA)-
induced differentiation (Yamanaka et al., 2000). Previous studies
in other cell lines have shown that Nat1 is homologous to the
translation initiation factor eIF4G, is located in the cytoplasmCell Stem Cell 15, September 4, 2014 ª2014 Elsevier Inc. 275
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mRNA; thus, the authors speculated that Nat1 binds to highly
structured 50UTRs and associates with translational initiation
factors. However, their study did not detect a difference in
cap-dependent or cap-independent translation in wild-type
and Nat1/ ESCs as measured by [35S]methionine incorpora-
tion and bicistronic luciferase assays, respectively. Despite the
negative results, it is important to note that these experiments
were conducted under steady-state pluripotency conditions,
not under the differentiation conditions in which they observed
the phenotype. Therefore, it remains plausible that Nat1 influ-
ences ESC differentiation through translational mechanisms,
and further studies should address the role of Nat1 in transitions
into and out of pluripotency.
Like Nat1, Rbm35a is a negative regulator of pluripotency.
Knockdown of Rbm35a inhibits ESC differentiation and pro-
motes somatic cell reprogramming by increasing expression of
Oct4, Nanog, and Sox2. Indeed, Rbm35a immunoprecipitation
and polysome profiling show that Rbm35a normally binds to
the 50UTR of Oct4 and Sox2 mRNAs, thus preventing them
from being loaded into polysomes (Fagoonee et al., 2013). In
addition, Rbm35a activity is not restricted to ESCs, because
the RBP is a regulator of alternative splicing in epithelial cell lines
(Warzecha et al., 2009) and has also been shown be expressed in
tumor cells where it binds to highly structured GC-rich 50UTRs of
oncogenes and prevents their translation (Leontieva and Ionov,
2009). ESCs themselves form teratomas when injected into
mice and share many properties with somatic tumors, including
limitless replicative potential. Therefore, Rbm35a suppression
may be an important component of maintaining ESC and tumor
cell immortality through both shared and unique molecular tar-
gets present in these different cellular contexts.
Ptbp1, another RBP that binds the 50UTR of gene transcripts,
also appears to control ESC growth through its regulation of the
cell cycle. Ptbp1 knockout ESCs have a proliferation defect with
a prolonged G2/M phase. This phenotype appears to be at least
in part secondary to problems with chromosomal segregation.
Bicistronic luciferase assays show that Ptbp1 binds to the
IRES of CDK11p58 and represses translation of this gene, high
levels of which are associated with a prolonged telophase
caused by chromosomal lagging. Overexpression of CDK11p58
in wild-type ESCs led to chromosome missegregation (Ohno
et al., 2011). Nevertheless, it is unclear whether or not overex-
pression of CDK11p58 is the sole contributor to the Ptbp1
knockout phenotype—a question that could be addressed
through global comparisons of mRNA and protein abundance
in wild-type and knockout cells. Notably, Ptbp1 has also been
extensively studied in other cell lines, where it has been impli-
cated in alternative splicing, alternative polyadenylation, mRNA
stability at the 30UTR, and IRES-driven translation (Boutz et al.,
2007; Castelo-Branco et al., 2004; Kosinski et al., 2003; Bushell
et al., 2006). It would be useful and informative for future studies
to examine whether these other well-known functions of Ptbp1
are also involved in pluripotency.
Multifunctional RBPs
In addition to Adar, Pum1, Rbm35a, and Ptbp1, other RBPs have
been proposed to play pleiotropic roles. For example, while
Lin28a clearly regulates let-7 biogenesis through directing uridy-276 Cell Stem Cell 15, September 4, 2014 ª2014 Elsevier Inc.lation of pre-let-7, it appears to have additional functions inde-
pendent of its relationship with let-7 (reviewed in Shyh-Chang
and Daley, 2013). Through binding to an AG-rich motif similar
to its pre-let-7 binding motif (Wilbert et al., 2012; Cho et al.,
2012), Lin28a both positively and negatively modulates the
translation of hundreds of mRNAs in human and mouse ESCs
(Wilbert et al., 2012; Cho et al., 2012; Peng et al., 2011; Xu
et al., 2009). How Lin28a achieves this incredibly complex
orchestration of its many targets remains to be determined.
Lin28a is an unusual example of an RBP attributed with multi-
ple functions in a single cellular context. To date, most studies
done on multifunctional RBPs, like Ptbp1 and Adar, only investi-
gate a single function of that RBP in ESCs, which does not
exclude the possibility that the RBP’s other proposed functions
are also important in supporting the pluripotency network. In
general, a number of RBPs, such Ilf2, Unr, and others, have
been genetically deleted in ESCs and shown to have an effect
on the ESC phenotype, but currently, the functions of these
RBPs can only be inferred from work done in other cell types.
As every study ascribes a different role to each of these RBPs,
it is unclear which, if any, are actually involved specifically in
the context of pluripotency.
A notable example providing evidence that RBPs can bemulti-
functional within a single context comes from a recent study of
the RNA helicases DDX5 and DDX17 not in pluripotent cells
but in the differentiation of myoblast and epithelial cell lines
(Dardenne et al., 2014). The authors showed that DDX5 and
DDX17 cooperate with the hnRNP H/F splicing factors to pro-
mote a differentiation-specific splice profile. At the same time,
DDX5 and DDX17 serve as transcriptional coregulators of key
differentiation transcription factors as well as miRNAs that, in
turn, negatively feed back on the expression of the RBPs them-
selves. It is unclear whether these two roles for DDX5 and DDX17
are physically linked; nevertheless, this story provides evidence
that an RBP can simultaneously function at the level of DNA
(transcription) and RNA (splicing).
Conclusions and Perspectives
It is without a doubt that posttranscriptional regulation by RBPs
contributes extensively to the establishment and maintenance
of, as well as exit from, the ESC state. The field remains relatively
young and largely uncharted, however, and there are many op-
portunities for further inquiry and discovery.
As described above and summarized in Table 1, a number of
studies have documented the significance of individual RBPs
in pluripotency based on knockdown and knockout models
demonstrating that perturbation of the RBP disrupts the wild-
type ESC phenotype. However, few probe the actual mecha-
nism by which the RBPs produce their effect in ESCs. Instead,
RBP function has been examined mostly in cancer cell lines and
cell-free biochemical assays, the in vivo relevance of which
needs to be more clearly characterized. The studies that do
delve into the molecular mechanisms in ESCs generally
examine only a limited number of targets. While the RBPs dis-
cussed here are not unique to ESCs, cell context likely in-
fluences their downstream effects on cell fate and cell fate
transitions significantly by providing a specific combination of
intracellular pathways with which these RBPs interface. Thus,
to reach a deep and unified understanding of the role of RBPs
Table 1. Summary of RBPs Associated with the Pluripotency Network
Category of
Posttranscriptional
Regulation RBP
Positive or Negative
Regulator of Pluripotency? Mechanism of Action in ESCs
Other Functions
(Not Validated in ESCs)
Alternative splicing FOX2 (RBM9, FXH) positive (Yeo et al., 2009) binds upstream of splice site
for exon exclusion; binds
downstream of splice site
for exon inclusion
SON positive (Lu et al., 2013) binds short introns with weak
splice sites
MBNL1, MBNL2 negative (Han et al., 2013) binds upstream of splice site
for exon inclusion; binds
downstream of splice site
for exon exclusion
SFRS2 (SC35) positive (Lu et al., 2014) regulates splicing of MBD2
Alternative
Polyadenylation
Fip1 positive (Lackford et al., 2014) promotes ESC-specific patterns
of alternative polyadenylation
RNA modification Zcchc11, Zcchc6
(TUTases)
positive (Hagan et al., 2009) inhibits let-7 biogenesis by
uridylating the pre-miRNA
ADAR (ADAR1) positive (Osenberg et al., 2010) drives A-to-I editing mRNA stability with Elavl1
(HuR); A-to-I editing of
pri-miRNAs to prevent their
processing; promote
pre-miRNA cleavage in
complex with Dicer
Mettl3, Mettl14 positive (Wang et al., 2014a) methylates adenosines in
mRNA, reducing transcript
stability
Nuclear export Thoc2, Thoc5
(members of THO
complex)
positive (Wang et al., 2013b) exports pluripotency gene
transcripts to the cytoplasm
for translation
RNA stability Trim71 (mLin41) positive (Chang et al., 2012;
Rybak et al., 2009; Loedige
et al., 2013; Worringer et al.,
2014)
binds Ago2 complexes,
enhancing ESC miRNAs’
inhibition of Cdkn1a expression,
which thus promotes ESC cell
cycle structure; antagonizes
Ago2 by ubiquitination;
degrades prodifferentiation
gene transcripts
Pum1 negative (Leeb et al., 2014) degrades pluripotency gene
transcripts
translation repressor
Brf1 negative (Tan and Elowitz, 2014) degrades pluripotency gene
transcripts
Translation Nat1 negative (Yamanaka et al., 2000) unclear translation repressor
Rbm35a negative (Fagoonee et al., 2013) prevents polysome loading of
pluripotency gene transcripts
alternative splicing
Ptbp1 positive (Ohno et al., 2011) binds to IRES and represses
translation of CDK11p58
alternative splicing;
alternative polyadenylation;
mRNA stability at 30UTR
Multifunctional Lin28a positive (reviewed in Shyh-
Chang and Daley, 2013)
inhibits let-7 biogenesis by
recruiting TUTases to uridylate
pre-let-7; translational
activation; mRNA degradation
with Drosha
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Reviewin pluripotency, we will need to make use of global approaches
like those that have already been successfully applied to
the field of epigenetics. In particular, we must dissect allRBP-RNA interactions systematically in ESC self-renewal and
differentiation conditions so as to examine not only how RNA
transcript levels change but also how the components ofCell Stem Cell 15, September 4, 2014 ª2014 Elsevier Inc. 277
Figure 2. TheMultifunctional RBP: The RNA
Regulon Revisited
(A and B) Alternative models for RBP regulation of
RNA metabolism. (A) In the classical view of the
RNA regulon, an RBP (blue object) binds multiple
transcripts to execute a single action on many
RNAs (purple, blue, and green). This in turn can
affect an array of cellular processes depending
on the nature of the mRNAs targeted. (B) In an
expanded version of the RNA regulon model, an
RBP not only has multiple targets but also acts on
those targets at multiple levels of intracellular
RNA metabolism. An example RBP shown here
regulates transcription, splicing, RNA stability,
and mRNA translation of a common set of tran-
scripts. While it is unlikely that such an RBP exists,
we propose that many RBPs will have a subset
of these functions on overlapping sets of targets.
Cell Stem Cell
Reviewribonucleoprotein (RNP) complexes are rearranged during tran-
sitions from one cell fate to another.
Intriguingly, as mentioned above under the subsection ‘‘Multi-
functional RBPs,’’ a number of RBPs appear to be involved in
multiple aspects of RNA metabolism in both the nucleus and
the cytoplasm. This observation may result from an RBP having
different roles in different cell types, multiple roles in a single cell
type, or somemix of the two. Regardless, it is almost certain that
the particular combination of targets and cofactors that an RBP
encounters influences its functions in context-specific ways—a
notion that expands upon the ‘‘RNA regulon’’ model originally
proposed by Jack Keene, in which an RBP bindsmultiple targets
to effect changes in various cellular processes (Keene, 2007). In
other words, it is possible that instead of regulating multiple
targets through just a single mechanism, one RBP could simul-
taneously participate in several layers of RNA metabolism
(Figure 2). In so doing, the RBP becomes part of increasingly
complex regulatory modules, with many opportunities for feed-
back and crosstalk, where one aspect of metabolism such as
translation can be linked to another such as splicing. Conse-
quently, perturbation of the RBP could have a cascading effect
on the molecular landscape of a cell and precipitate drastic
switches in cellular identity. Also, it follows that disrupting sub-
sets of the mRNA targets or cofactors of any one RBP could
affect parallel pathways by shifting the RBP’s dominant activities
to different genes or even different regulatory modules alto-
gether. For example, a decrease in the levels of a cofactor that
enables an RBP to regulate splicing could drive that RBP to shift
its main activity to transcription.
Moving forward, it will be critical to investigate RBPs at the ge-
nomics level in biologically relevant cell types, focusing on those
states in which the RBPs are demonstrated to play significant
roles. Studying RBPs in ESCs provides an excellent starting278 Cell Stem Cell 15, September 4, 2014 ª2014 Elsevier Inc.context to achieve such a goal, because
not only can ESCs provide unlimited
untransformed material for large-scale
genomic studies, they can also be differ-
entiated down any cellular lineage to
determine how context changes protein
function. Thus, experimental tools and
platforms developed in the ESC systemcan be used to study a multitude of cell types that comprise
the mammalian body plan.
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